Drug cost containment policies in Italy: Are they really effective in the long-run? The case of minimum reference price

Health Policy

Volumn 50, Issue 3, 2000, Pages 197-218

  Atella, Vincenzo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cost containment policy; Drug demand; Dynamic simulation; Italy

Indexed keywords

ARTICLE; CONSUMER; COST CONTROL; DRUG COST; DRUG UTILIZATION; ECONOMIC ASPECT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; INCOME; ITALY; LAW; MATHEMATICAL MODEL; REFERENCE VALUE; SIMULATION; WELFARE;

ADULT; COST CONTROL; DRUG COSTS; DRUG INDUSTRY; FEMALE; FINANCING, GOVERNMENT; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE BENEFITS; ITALY; MALE; MODELS, ECONOMETRIC; PHARMACEUTICAL SERVICES; PRIVATE SECTOR; PUBLIC SECTOR;

EID: 0033960516     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(99)00070-6     Document Type: Article

References (24)

1. Fattore G., Jommi C. The new pharmaceutical policy in Italy. Health Policy. 46:1998;21-41.
2. Grossman M. On the concept of health capital and the demand for health. Journal of Political Economy. 80:1972;180-223.
3. Phelps C. The demand for health insurance: a theoretical and empirical investigation. The Rand Corporation 1974; R-1197-NC.
4. Atella V. Spesa farmaceutica pubblica e controllo dei prezzi: venti anni di problemi e incomprensioni. MECOSAN. 27:1997;43-52.
5. Fuchs V. The supply of surgeons and the demand for operations. Journal of Human Resources. Supplement:1978;35-56.
6. Auster R.D., Oxaca R.L. Identification of supplier induced demand in the health care sector. Journal of Human Resources. 16:1981;327-342.
7. Hunt-McCool J., Kiker B.F., Chu Ng Y. Estimates of the demand for medical care under different functional forms. Journal of Applied Econometrics. 9:1994;201-218.
8. Alexander D.L., Flynn J.E., Linkins L. Estimates of the demand for ethical pharmaceutical drugs across countries and time. Applied Economics. 26:1994;821-826.
9. Coulson N.E., Stuart B.C. Insurance choice and the demand for prescription drugs. Southern Economic Journal. 61:1995;1146-1157.
10. Baye M.R., Maness R., Wiggins S.N. Demand system and the true subindex of the cost of living pharmaceuticals. Applied Economics. 29:1997;1179-1189.
11. Huttin C. Income distribution and consumer demand for health services. The case of medicines in the USA. Applied Economics. 29:1997;497-503.
12. Wiggins SN. Pioneering products, demand estimation, and social welfare in the pharmaceutical industry. Working Paper 1993, Texas A&M University.
13. Leibowitz A., Manning W.G., Newhouse J.P. The demand for prescription drugs as a function of cost-sharing. Social Science Medicine. 21:1985;1063-1069.
14. Birch S. Relationship between increasing prescription charges and consumption in groups not exempt from charges. Journal of Royal College of General Practitioners. 36:1986;154-156.
15. O'Brien B. The effect of patient charges on the utilization of prescription medicines. Journal of Health Economics. 8:1989;109-132.
16. Hurley J., Johnson N.A. The effects of co-payments within drug reimbursement programs. Canadian Public Policy. 17:1991;473-485.
17. Huttin C. The use of prescription charges. Health Policy. 27:1994;53-73.
18. Atella V., Roberti P. Il contenimento della spesa farmaceutica: l'impatto sulle famiglie. Rossi N. Quarto rapporto CNEL sulla distribuzione e redistribuzione del reddito in Italia. 1998;367-402 Il Mulino, Bologna.
19. CENSIS, Consumi e spesa farmaceutica. Milano: Franco Angeli Editore, 1997.
20. Farmindustria, Indicatori farmaceutici, various years.
21. Ministero del Tesoro, Relazione generale sulla situazione economica del paese, Istituto Poligrafico dello Stato, Roma, various years.
22. ISTAT, Bollettino mensile di statistica, various years.
23. ISTAT, Annuario Statistico Italiano, various years.
24. ISTAT, Conti economici nazionali, various years.